Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Allahyari A, Seddigh-Shamsi M, Mahmoudi M, Amel Jamehdar S, Amini M, Mozdourian M, Javidarabshahi Z, Eslami Hasan Abadi S, Amini S, Sedaghat A, Emadzadeh M, Moeini Nodeh M, Rahimi H, Bari A, Mozaheb Z, Kamandi M, Ataei Azimi S, Abrishami M, Akbarian A, Ataei P, Allahyari N, Hasanzadeh S, Saeedian N.
Allahyari A, et al. Among authors: javidarabshahi z.
Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2.
Int Immunopharmacol. 2021.
PMID: 33582019
Free PMC article.
Clinical Trial.